Van Poznak C - Search Results

1

Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms.

Henry NL, Banerjee M, Wicha M, Van Poznak C, Smerage JB, Schott AF, Griggs JJ, Hayes DF. Henry NL, et al. Among authors: van poznak c. Cancer. 2011 Dec 15;117(24):5469-75. doi: 10.1002/cncr.26230. Epub 2011 Jun 20. Cancer. 2011. PMID: 21692065 Free article. Clinical Trial.

2

Clinical management of osteoporosis in women with a history of breast carcinoma.

Van Poznak C, Sauter NP. Van Poznak C, et al. Cancer. 2005 Aug 1;104(3):443-56. doi: 10.1002/cncr.21201. Cancer. 2005. PMID: 15968687 Free article. Review.

3

The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer.

Van Poznak C. Van Poznak C. Cancer Invest. 2006 Feb;24(1):110-2. doi: 10.1080/07357900500449652. Cancer Invest. 2006. PMID: 16467002

4

Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?

Van Poznak CH, Hayes DF. Van Poznak CH, et al. J Natl Cancer Inst. 2006 Sep 20;98(18):1261-3. doi: 10.1093/jnci/djj387. J Natl Cancer Inst. 2006. PMID: 16985239 No abstract available.

5

Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancer.

Fornier MN, Seidman AD, Lake D, D'Andrea G, Bromberg J, Robson M, Van Poznak C, Panageas KS, Atienza M, Norton L, Hudis C. Fornier MN, et al. Among authors: van poznak c. Clin Cancer Res. 2007 Jan 1;13(1):223-7. doi: 10.1158/1078-0432.CCR-06-1731. Clin Cancer Res. 2007. PMID: 17200358 Clinical Trial.

6

Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial.

Van Poznak C, Hannon RA, Mackey JR, Campone M, Apffelstaedt JP, Clack G, Barlow D, Makris A, Eastell R. Van Poznak C, et al. J Clin Oncol. 2010 Feb 20;28(6):967-75. doi: 10.1200/JCO.2009.24.5902. Epub 2010 Jan 11. J Clin Oncol. 2010. PMID: 20065185 Clinical Trial.

7

A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography.

Henry NL, Jacobson JA, Banerjee M, Hayden J, Smerage JB, Van Poznak C, Storniolo AM, Stearns V, Hayes DF. Henry NL, et al. Among authors: van poznak c. Cancer. 2010 Sep 15;116(18):4360-7. doi: 10.1002/cncr.25385. Cancer. 2010. PMID: 20549827 Free PMC article.

8

Lipid profiles within the SABRE trial of anastrozole with and without risedronate.

Van Poznak C, Makris A, Clack G, Barlow DH, Eastell R. Van Poznak C, et al. Breast Cancer Res Treat. 2012 Aug;134(3):1141-7. doi: 10.1007/s10549-012-2147-9. Epub 2012 Jul 5. Breast Cancer Res Treat. 2012. PMID: 22763465 Free PMC article. Clinical Trial.

9

Potential implications of adjuvant endocrine therapy for the oral health of postmenopausal women with breast cancer.

Taichman LS, Havens AM, Van Poznak CH. Taichman LS, et al. Breast Cancer Res Treat. 2013 Jan;137(1):23-32. doi: 10.1007/s10549-012-2217-z. Epub 2012 Sep 18. Breast Cancer Res Treat. 2013. PMID: 22986813 Free PMC article. Review.

10

Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA.

Rae JM, Regan MM, Thibert JN, Gersch C, Thomas D, Leyland-Jones B, Viale G, Pusztai L, Hayes DF, Skaar T, Van Poznak C. Rae JM, et al. Among authors: van poznak c. J Natl Cancer Inst. 2013 Sep 4;105(17):1332-4. doi: 10.1093/jnci/djt204. Epub 2013 Aug 19. J Natl Cancer Inst. 2013. PMID: 23958736 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters